NCT04522245

Brief Summary

The aim of this study is to compare brain changes in individuals with overweight or obesity enrolled in either the Noom Healthy Weight program or a matched control. The study objectives (primary and secondary) are to measure brain change reported as ERP and EEG data over a 16-week timeframe. Additionally, we will explore changes in the default mode network (resting-state asymmetry in EEG measurements), changes in executive functioning, quality of life, mood, and salivary markers as they relate to EEG data.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable obesity

Timeline
Completed

Started Oct 2020

Shorter than P25 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 4, 2020

Completed
17 days until next milestone

First Posted

Study publicly available on registry

August 21, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2021

Completed
Last Updated

July 20, 2021

Status Verified

July 1, 2021

Enrollment Period

6 months

First QC Date

August 4, 2020

Last Update Submit

July 19, 2021

Conditions

Keywords

EEG, mhealth, weight loss, CBT, cognitive behavior therapy

Outcome Measures

Primary Outcomes (4)

  • Change in Flanker task performance: Intervention vs control

    Change in amplitude and latency in conflict monitoring stage at 16 weeks

    16 weeks

  • Change in behavioral inhibition

    Change from baseline Flanker task performance at 16 weeks

    16 weeks

  • Change in behavioral inhibition

    Change from baseline n-back task performance at 16 weeks

    16 weeks

  • Change in behavioral inhibition

    Change from baseline Stroop test at 16 weeks

    16 weeks

Secondary Outcomes (3)

  • Change in EEG data: Successful intervention (5% weight loss) in higher engagement subgroup (successful program completers) vs control

    16-week

  • Comparison of EEG data in program starters to successful program completers

    16-week

  • Within-subject comparison for EEG data

    16-week

Other Outcomes (7)

  • Change in Positive and Negative Affect Schedule (PANAS-SF)

    16-week

  • Change in quality of life outcome measure scoring (PROMIS-29)

    16-week

  • Change in eating behavior measure scoring (Three-Factor Eating Questionnaire)

    16-week

  • +4 more other outcomes

Study Arms (2)

Control

PLACEBO COMPARATOR

Matched control group (Noom-branded 'healthy eating' short guide on weight loss).

Other: Matched Control

Noom Health Weight Program

EXPERIMENTAL
Behavioral: Noom Healthy Weight; mobile behavior change program for weight loss.

Interventions

The mobile cognitive behavior change program follows guidelines from the Obesity Society's "2013 Guidelines for the Management of Overweight and Obesity in Adults" NIH "Practical Guide on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults". There are 52 weeks of curriculum with 1-3 articles to read per day. Users are requested to perform weight logging once daily and food logging after each meal. Users are assigned human coaches and are able to interact with them via in-app messaging or phone communication. Users are also assigned to support groups via in-app messaging.

Noom Health Weight Program

Matched control group (Noom-branded 'healthy eating' short guide on weight loss).

Control

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Each subject must be able to understand and provide informed consent
  • Between the ages 18-60 years
  • Self-report of good health
  • Overweight or obesity (BMI ≥ 25)
  • Able to meet our criteria of adherence to the program
  • Able to attend in-person visit in Long Island, NY

You may not qualify if:

  • Inability or unwillingness to give written informed consent or comply with the study
  • Visual impairment that cannot be corrected with glasses or contact lenses
  • Any indication of drug, alcohol or medicine abuse.
  • Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data
  • Presence of a brain injury, psychiatric disorders, seizure disorders, and other neurological conditions
  • Reported eating disorder
  • Currently pregnant or 6 months postpartum
  • Planning to become pregnant within the next 5 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Focus Feedback

Commack, New York, 11725, United States

Location

MeSH Terms

Conditions

ObesityHealth BehaviorWeight LossColor Vision Defects

Interventions

Case-Control Studies

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehaviorBody Weight ChangesVision DisordersSensation DisordersNeurologic ManifestationsNervous System DiseasesCone DystrophyEye Diseases, HereditaryEye Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic StudiesEpidemiologic Study CharacteristicsEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Andreas Michaelides, PhD

    Chief of Psychology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief of Psychology

Study Record Dates

First Submitted

August 4, 2020

First Posted

August 21, 2020

Study Start

October 1, 2020

Primary Completion

March 15, 2021

Study Completion

July 15, 2021

Last Updated

July 20, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations